Perspectives of impaired glucose tolerance management in patients with metabolic syndrome

Aim. To assess the effectiveness of vildagliptin, its effects on visceral obesity (VO), carbohydrate and lipid metabolism parameters, and circadian profile (CP) of blood pressure (BP) in patients with metabolic syndrome (MS), Stage I arterial hypertension (AH), and impaired glucose tolerance (IGT)....

Full description

Saved in:
Bibliographic Details
Main Authors: K. P. Ivanov, V. B. Mychka, Yu. V. Zhernakova, E. V. Tishina, S. N. Tolstov, V. P. Masenko, I. E. Chazova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2011-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1900
Tags: Add Tag
No Tags, Be the first to tag this record!